Lifecore Biomedical Earnings Report: Q2 Overview - Lifecore Biomedical (NASDAQ:LFCR)

Lifecore Biomedical (NASDAQ:LFCR) announced its Q2 earnings on Thursday, January 2, 2025 at 04:05 PM.

Here's a breakdown of the earnings report.

Lifecore Biomedical beat estimated earnings by 19.0%, reporting an EPS of $-0.25 versus an estimate of $-0.31.

Revenue was up $2.41 million from the same period last year.

The company missed on EPS by $0.07 in the last quarter, resulting in a 14.000000000000002% increase share price change the following day.

To track all earnings releases for Lifecore Biomedical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

To add Benzinga News as your preferred source on Google, click here.

Lifecore Biomedical (NASDAQ:LFCR) announced its Q2 earnings on Thursday, January 2, 2025 at 04:05 PM.

Here's a breakdown of the earnings report.

Lifecore Biomedical beat estimated earnings by 19.0%, reporting an EPS of $-0.25 versus an estimate of $-0.31.

Revenue was up $2.41 million from the same period last year.

The company missed on EPS by $0.07 in the last quarter, resulting in a 14.000000000000002% increase share price change the following day.

To track all earnings releases for Lifecore Biomedical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

To add Benzinga News as your preferred source on Google, click here.